You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histamine H1 Receptor Antagonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Burns Trial in Shanghai (Cetirizine, Midazolam and Fentanyl)

Recruiting
  • Burns
  • Shanghai, Shanghai, China
    Department of Burn, Ruijin Hospital, Shanghai Jiao Tong Universi
Nov 6, 2023

Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise

Active, not recruiting
  • Exercise
  • Histamine
  • Placebo: Placebo + exercise training.
  • +2 more
  • Ghent, Oost-Vlaanderen, Belgium
    Department of movement and sports sciences, Ghent University, Be
Nov 8, 2022

Histamine Trial in Ghent (Placebo, H1 blockade: Telfast: 180mg Fexofenadine, Resistance training)

Recruiting
  • Histamine
  • Placebo
  • +2 more
  • Ghent, Oost-Vlaanderen, Belgium
    Department of movement and sports sciences, Ghent University, Be
Nov 29, 2023

Efficacy and Safety Trial in Beijing (Clemastine, Saline Solution)

Completed
  • Efficacy and Safety
  • Beijing, Beijing, China
    Cardiovascular Institute and Fuwai Hospital, CAMS&PUMC
Jan 10, 2020

Switching H1-antagonist Clemastine to Cetirizine in

Active, not recruiting
  • Solid Tumor
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus University Medical Center
Sep 8, 2023

H2 Receptor Antagonist and Proton Pump Inhibitor on Positivity

Not yet recruiting
  • COVID-19
  • No intervention (Retrospective Cohort Observational)
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 6, 2021

Drug Interaction Trial in Brisbane (Telaglenastat, Famotidine, Placebo for famotidine)

Completed
  • Drug Interaction
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic (formerly Q-Pharm)
Mar 8, 2021

Exercise Training, Physical Activity Trial in Gent (Lactose, Fexofenadine Hydrochloride, Famotidine)

Completed
  • Exercise Training
  • Physical Activity
  • Lactose
  • +3 more
  • Gent, Oost-Vlaanderen, Belgium
    Department of Movement and Sports Sciences, Ghent University
Jul 29, 2021

Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

Completed
Has Results
  • Epidermolysis Bullosa
  • Serlopitant Tablet
  • Placebo Oral Tablet
  • Redwood City, California
    Stanford University
Nov 30, 2022

Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)

Recruiting
  • Safety Issues
  • +2 more
  • Washington, District of Columbia
    Georgetown University
Dec 1, 2022

Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Kineret 100 MG in 0.67 ML Prefilled Syringe
  • +3 more
  • Frankfurt, Germany
    University Hospital Goethe University Frankfurt
Aug 23, 2022

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +3 more
Jan 17, 2023

Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)

Not yet recruiting
  • Acute Respiratory Distress Syndrome
  • Placebo
  • Ondansetron Injection
  • Montréal, Quebec, Canada
    Hôpital Sacré-Coeur de Montréal
Aug 22, 2022

Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)

Not yet recruiting
  • Depressive Disorder, Major
  • Anxiety Disorder
  • Nociceptin Receptor Antagonist
  • Aversive stimuli
  • (no location specified)
Nov 3, 2022

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

Not yet recruiting
  • Pericarditis
  • IL1RA Antibody Assay
  • suPAR Testing
  • Homburg, Germany
  • +8 more
Jun 22, 2023

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Netosis During COVID-19, Under Treatment With

Active, not recruiting
  • Covid19
    • Paris, France
    • +1 more
    Mar 30, 2022

    Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

    Enrolling by invitation
    • Chronic Kidney Diseases
    • Aurora, Colorado
    • +5 more
    Oct 18, 2022

    Protamine Adverse Reaction Trial in Bangkok (Chlorpheniramine and ranitidine, 0.9% Normal Saline)

    Completed
    • Protamine Adverse Reaction
    • Chlorpheniramine and ranitidine
    • 0.9% Normal Saline
    • Bangkok, Thailand
      Siriraj Hospital
    Aug 31, 2021

    Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

    Active, not recruiting
    • Breast Neoplasms
    • Chuo Ku, Japan
    • +1 more
    Dec 19, 2022

    Primary Aldosteronism Trial in Montréal (Renin measurements)

    Not yet recruiting
    • Primary Aldosteronism
    • Renin measurements
    • Montréal, Quebec, Canada
      Hôpital du Sacré-Coeur de Montréal
    Oct 30, 2023

    Spinal Cord Injuries Trial in Toledo (Rimonabant)

    Not yet recruiting
    • Spinal Cord Injuries
    • Toledo, Spain
      Hospital Nacional de Paraplejicos
    Nov 14, 2022

    Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

    Recruiting
    • Adamantinomatous Craniopharyngioma
    • Recurrent Adamantinomatous Craniopharyngioma
    • Aurora, Colorado
    • +17 more
    Jan 8, 2023

    Advanced Solid Tumor, Breast Cancer, Non Small Cell Lung Cancer Trial (MB1707)

    Not yet recruiting
    • Advanced Solid Tumor
    • +4 more
    • (no location specified)
    Jul 18, 2022

    Pancreatitis, Acute Trial in Denmark, Sweden (Placebo treatment, Naldemedine 0.2 MG Oral Tablet)

    Recruiting
    • Pancreatitis, Acute
    • Placebo treatment
    • Naldemedine 0.2 MG Oral Tablet
    • Aalborg, Jutland, Denmark
    • +4 more
    Mar 7, 2022